Publications by authors named "Emmanuel A Tsochatzis"

Claim this Profile
R
Reply.
Manuel Luis Rodríguez-Perálvarez, Antonio Manuel Gómez-Orellana, Emmanuel A Tsochatzis

Clin Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender-Equity Model for Liver Allocation Using Artificial Intelligence (GEMA-AI) for Waiting List Liver Transplant Prioritization.
Antonio Manuel Gómez-Orellana, Manuel Luis Rodríguez-Perálvarez, David Guijo-Rubio, Pedro Antonio Gutiérrez, Avik Majumdar, Emmanuel A Tsochatzis

Clin Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease.
Jimmy Che-To Lai, Boyu Yang, Hye Won Lee, Huapeng Lin, Emmanuel A Tsochatzis

Gut· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MetALD: Diagnosis and Prognosis With Non-Invasive Tests.
Nikolaj Torp, Mads Israelsen, Stine Johansen, Georg Semmler, Camilla Dalby Hansen, Emmanuel A Tsochatzis

Aliment Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing MASLD Through Preventive Hepatology: Integrating Policy Reform, Public Health and Personalised Care.
Zobair M Younossi, Vincent Wai-Sun Wong, Emmanuel A Tsochatzis, Laurent Castera, Michael Betel

Liver Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Prediction Models of First Decompensation in Compensated Advanced Chronic Liver Disease: A Meta-Analysis.
Angus W Jeffrey, James Chen, Andrew Chin, Emmanuel A Tsochatzis, Avik Majumdar

Clin Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Assessment of Liver Fibrosis.
Laurent Castera, Mary E Rinella, Emmanuel A Tsochatzis

N Engl J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for advanced steatotic liver disease.
Stine Johansen, Fredrik Åberg, Emmanuel A Tsochatzis, Aleksander Krag

Lancet Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving diagnosis of liver fibrosis into the community.
Elisa Pose, Salvatore Piano, Maja Thiele, Núria Fabrellas, Emmanuel A Tsochatzis

J Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The People-First Liver Charter.
Jeffrey V Lazarus, Dana Ivancovsky Wajcman, Silvana Pannain, Paul N Brennan, Melina I Manolas, Emmanuel A Tsochatzis

Nat Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Fibrosis Testing in Patients With Type 2 Diabetes: The Time Is Now.
Mirko Zoncapè, Emmanuel A Tsochatzis

Diabetes Care· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction-associated steatotic liver disease.
Alina M Allen, Jeffrey V Lazarus, Naim Alkhouri, Mazen Noureddin, Vincent Wai-Sun Wong, Emmanuel A Tsochatzis

Hepatol Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting at-risk steatotic liver disease and liver fibrosis in the community.
Leon A Adams, Maja Thiele, Emmanuel A Tsochatzis

Hepatology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis.
Antonio Liguori, Mirko Zoncapè, Giovanni Casazza, Philippa Easterbrook, Emmanuel A Tsochatzis

Lancet Gastroenterol Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Treatment in MASLD: The Next Frontier.
Emmanuel A Tsochatzis, Mazen Noureddin

Clin Gastroenterol Hepatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of transient elastography for predicting hepatocellular carcinoma in chronic hepatitis B patients: Editorial on "Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis".
Mirko Zoncapè, Emmanuel A Tsochatzis

Clin Mol Hepatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to correspondence on "Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis".
Mirko Zoncapè, Emmanuel A Tsochatzis

Clin Mol Hepatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake.
Emil Deleuran Hansen, Nikolaj Torp, Stine Johansen, Johanne Kragh Hansen, Marianne Lerbæk Bergmann, Emmanuel A Tsochatzis

JHEP Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap for clinical trials in MASH-related compensated cirrhosis.
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, Ramón Bataller, Annalisa Berzigotti, Emmanuel A Tsochatzis

Nat Rev Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis.
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, Ramón Bataller, Annalisa Berzigotti, Emmanuel A Tsochatzis

Nat Rev Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steatotic liver disease.
Mads Israelsen, Sven Francque, Emmanuel A Tsochatzis, Aleksander Krag

Lancet· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of the Baveno VI Criteria Compared With Endoscopy for High-Risk Varices in Patients With Child-Pugh A Cirrhosis.
Elena Pizzo, Tuba Saygın Avşar, Juan G Abraldes, Joan Genesca, Emmanuel A Tsochatzis

Clin Gastroenterol Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms.
Margarita Papatheodoridi, Victor De Ledinghen, Monica Lupsor-Platon, Fabrizio Bronte, Jerome Boursier, Emmanuel A Tsochatzis

J Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement.
Emma Short, Ian M Adcock, Bilal Al-Sarireh, Ann Ager, Ramzi Ajjan, Emmanuel A Tsochatzis

medRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: A qualitative exploration of challenges and barriers.
Emmanuel A Tsochatzis, Luca Valenti, Maja Thiele, Sophie Péloquin, Patrice Lazure

Liver Int· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis